Stem Point Capital LP Portfolio Holdings
Stem Point Capital LP
- $340 Billion
- Q2 2024
Stem Point Capital LP has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $340 Billion distributed in 44 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Syndax Pharmaceuticals Inc with a value of $29B, Roivant Sciences Ltd. with a value of $28.7B, Immunovant, Inc. with a value of $26.7B, Crinetics Pharmaceuticals, Inc. with a value of $24.7B, and Merus N.V. with a value of $17.1B.
Examining the 13F form we can see an decrease of $38.1B in the current position value, from $378B to 340B.
Stem Point Capital LP is based out at New York, NY
Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.